Summary
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The report forecast global Orally Disintegrating Tablet market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025.
The report offers detailed coverage of Orally Disintegrating Tablet industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Orally Disintegrating Tablet by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Orally Disintegrating Tablet market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Oceania], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Orally Disintegrating Tablet according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Orally Disintegrating Tablet company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:

Market Overview

, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Geography
Part 3-4:
Asia-Pacific Market by Type, Application & Geography
Part 5-6:
Europe Market by Type, Application & Geography
Part 7-8:
North America Market by Type, Application & Geography
Part 9-10:
South America Market by Type, Application & Geography
Part 11-12:
Middle East & Africa Market by Type, Application & Geography
Part 13:
Company information, Sales, Cost, Margin etc.
Part 14:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Oceania]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Market by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others